Unassociated Document

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934


Date of Report (Date of earliest event reported): July 31, 2008


NovaMed, Inc.
(Exact Name of Registrant as Specified in Charter)

Delaware
  
0-26625
  
36-4116193
(State or Other Jurisdiction of incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)
         
980 North Michigan Avenue, Suite 1620, Chicago, Illinois
  
60611
(Address of Principal Executive Offices)
  
(Zip Code)

Registrant’s telephone number, including area code (312) 664-4100

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act

[ ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act

[ ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act

[ ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act


Section 2 - Financial Information

Item 2.02 Results of Operations and Financial Condition.
 
On July 31, 2008, NovaMed, Inc. (the “Company”) issued a press release announcing its results of operations for the period ended June 30, 2008. The Company also announced that its Board of Directors has adopted a program to repurchase from time to time at management’s discretion up to $8 million of the Company’s common stock in the open market or in private transaction during the 12-month period ending July 31, 2009 at prevailing market prices. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.
 
The information in this Form 8-K and Exhibit 99.1 attached hereto shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.
 
Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits

(c)
Exhibits

  Exhibit Number Title
     
99.1
Press release of NovaMed, Inc. dated July 31, 2008


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
  NovaMed, Inc.
 
 		  
 		  
 
Dated: July 31, 2008 By:   /s/ Scott T. Macomber
 
Scott T. Macomber
  Executive Vice President and Chief Financial Officer
 

EXHIBIT INDEX

Exhibit No. Exhibit
   
99.1
Press release of NovaMed, Inc. dated July 31, 2008